-
RBC: Neos Therapeutics Has 70% Upside, $500 Million Opportunity
Monday, August 17, 2015 - 9:58am | 249RBC Capital Markets analyst Randall Stanicky initiated Neos Therapeutics Inc (NASDAQ: NEOS) at an Outperform with a $35 price target – 70 percent above Friday's $20.63 closing price. Stanicky pointed to "bullish feedback from our physician survey" that suggests that the...